Chelsea Therapeutics Reports Q3 2006 Results
14th Nov 2006, 16:19 GMT
Chelsea Therapeutics Int'l presented a quarterly update on the Company's development progress, reported financial results for Q3 2006 and confirmed that it remains on track to meet key milestones in 2006 and 2007.
Chelsea Therapeutics Reports Q3 2006 Results related news:
- Chelsea Therapeutics Reports Third Quarter 2006 Results — ArriveNet : Press Releases
- Opexa Reports Q3 Financial Results — Nephrology/ Dialysis News from StratCenter.com
- InSite Vision Reports Q3 2006 Financial Results — Operations-Related News from StratCenter.com
- CytRx Reports Q3 Financial Results — Bio-Technology News from StratCenter.com
- eGene Reports a Profitable Quarter Result and Revenue Increases 273% in Q3 2006 Compared to Q3 2005 — Operations-Related News from StratCenter.com
- Stratagene Reports Q3 Results — Laboratory News from StratCenter.com
- Cardiogenesis Reports Q3 2006 Results — Surgery News from StratCenter.com
- Chelsea Therapeutics posts 3Q loss — Latest news from Charlotte Business Journal
- Adherex Reports Q3 2006 Financial Results — Radiology News from StratCenter.com
- Favrille Reports Q3 2006 Financial Results — StratWire - Business of Healthcare NewsFeed
Latest news from Operations-Related News from StratCenter.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Genelabs reports lower Q3 loss
- Solexa posts narrowed Q3 loss
- Abbott's Humira Positive in 2 Studies